| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Furey Raymond J. | EVP, GC, CCO & Corp Sec | RIGEL PHARMACEUTICALS, INC., 611 GATEWAY BLVD, SUITE 900, SOUTH SAN FRANCISCO | /s/ Raymond Furey | 04 Feb 2026 | 0001577899 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RIGL | Common Stock | Tax liability | $142,888 | -3,968 | -10% | $36.01 | 35,862 | 02 Feb 2026 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Includes 1,000 shares acquired under the Issuer's stock purchase plan. |